These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
667 related articles for article (PubMed ID: 19138008)
1. Our experience of melanoma thickness as a predictor of outcome of sentinel node biopsy. Homolak D; Vucetić B; Puljiz Z; Blajć I; Vurnek Zivković M; Situm M Coll Antropol; 2008 Oct; 32 Suppl 2():57-60. PubMed ID: 19138008 [TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary? Nahabedian MY; Tufaro AP; Manson PN Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009 [TBL] [Abstract][Full Text] [Related]
3. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma]. Keijzer R; Bril H; van der Loo EM; de Graaf PW Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391 [TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study. Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169 [TBL] [Abstract][Full Text] [Related]
5. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183 [TBL] [Abstract][Full Text] [Related]
6. The prognostic importance of sentinel lymph node biopsy in thin melanoma. Ranieri JM; Wagner JD; Wenck S; Johnson CS; Coleman JJ Ann Surg Oncol; 2006 Jul; 13(7):927-32. PubMed ID: 16788753 [TBL] [Abstract][Full Text] [Related]
7. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis. Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039 [TBL] [Abstract][Full Text] [Related]
8. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients. Gutzmer R; Al Ghazal M; Geerlings H; Kapp A Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648 [TBL] [Abstract][Full Text] [Related]
9. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma. Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497 [TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy in elderly irish patients with malignant melanoma. Moran DE; Smith MJ; O'Sullivan MJ; Bannon H; Crotty TB; Collins CD; Skehan SJ; O'Higgins N; McDermott EW; Evoy D; Hill AD Ir Med J; 2007 Apr; 100(4):422-4. PubMed ID: 17566474 [TBL] [Abstract][Full Text] [Related]
11. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients. Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144 [TBL] [Abstract][Full Text] [Related]
12. Desmoplastic and neurotropic melanoma. Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878 [TBL] [Abstract][Full Text] [Related]
13. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma. Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885 [TBL] [Abstract][Full Text] [Related]
14. Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for disease-free survival, distant-metastasis-free survival, and overall survival. Moehrle M; Schippert W; Rassner G; Garbe C; Breuninger H Dermatol Surg; 2004 Oct; 30(10):1319-28. PubMed ID: 15458529 [TBL] [Abstract][Full Text] [Related]
16. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma. Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039 [TBL] [Abstract][Full Text] [Related]
17. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node. Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880 [TBL] [Abstract][Full Text] [Related]
18. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma. Aloia TA; Gershenwald JE; Andtbacka RH; Johnson MM; Schacherer CW; Ng CS; Cormier JN; Lee JE; Ross MI; Mansfield PF J Clin Oncol; 2006 Jun; 24(18):2858-65. PubMed ID: 16782925 [TBL] [Abstract][Full Text] [Related]
19. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Nowecki ZI; Rutkowski P; Michej W Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535 [TBL] [Abstract][Full Text] [Related]
20. The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy. Zapas JL; Coley HC; Beam SL; Brown SD; Jablonski KA; Elias EG J Am Coll Surg; 2003 Sep; 197(3):403-7. PubMed ID: 12946795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]